Am. J. Respir. Crit. Care Med., Vol 154, No. 3, Sep 1996, 617-624.
Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group
C Brun-Buisson, F Doyon and J Carlet
Service de Reanimation Medicale, Hopital Henri Mondor, Creteil, France.
To examine the relationships between bacteremia and severe sepsis and
assess the influence of characteristics of infection on the risk of severe
sepsis and outcome of bacteremia, we analyzed all clinically significant
episodes of bacteremia occurring during a 2-mo prospective survey of 85,750
admissions to adult wards and intensive care units (ICUs) of 24 hospitals
in France. Incidence rates of bacteremia and of bacteremic severe sepsis
were 9.8 (95% CI: 9.2 to 10.5) and 2.6 (95% CI: 2.2 to 2.9), respectively,
per 1,000 adult admissions; these rates were eight and 32 times higher in
ICUs than in wards, respectively. Independent risk factors for severe
sepsis during bacteremia included age (p < 0.001) and an intraabdominal
(p < 0.001), pulmonary (p < 0.001), neuromeningeal (p = 0.004), or
multiple (p < 0.001) source of bacteremia, but not categories of
organisms involved. The probability of death at 28 d after bacteremia was
25% (95% CI: 23% to 29%), and was 54% (95% CI: 48% to 61%) in patients with
bacteremic severe sepsis. The risk of death after bacteremia increased with
age (p < 0.001), a rapidly or ultimately fatal underlying disease (p
< 0.001), and the presence of severe sepsis (p < 0.001), shock (p =
0.03), and infection caused by gram-positive organisms other than
coagulase-negative staphylococci, relative to other organisms (p <
0.001). A primary urinary tract source of infection was associated with a
better prognosis (p = 0.03). We conclude that whereas sources of infection
influence both the risk of severe sepsis and the outcome of bacteremia, the
microbiologic characteristics of infection influence only the outcome, with
gram-negative organisms and coagulase-negative staphylococci posing a
lesser risk than other organisms.
This article has been cited by other articles:

|
 |

|
 |
 
M.-P. Bonnet, H. Beloeil, D. Benhamou, J.-X. Mazoit, and K. Asehnoune
The {micro} Opioid Receptor Mediates Morphine-Induced Tumor Necrosis Factor and Interleukin-6 Inhibition in Toll-Like Receptor 2-Stimulated Monocytes
Anesth. Analg.,
April 1, 2008;
106(4):
1142 - 1149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Munford
Sensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant?
Infect. Immun.,
February 1, 2008;
76(2):
454 - 465.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Lagan, D. D. Melley, T. W. Evans, and G. J. Quinlan
Pathogenesis of the systemic inflammatory syndrome and acute lung injury: role of iron mobilization and decompartmentalization
Am J Physiol Lung Cell Mol Physiol,
February 1, 2008;
294(2):
L161 - L174.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. BOSSHART and M. HEINZELMANN
Targeting Bacterial Endotoxin: Two Sides of a Coin
Ann. N.Y. Acad. Sci.,
January 1, 2007;
1096(1):
1 - 17.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W J Schuiling, P J W Dennesen, J T. J Tans, L M Kingma, A Algra, and G J E Rinkel
Troponin I in predicting cardiac or pulmonary complications and outcome in subarachnoid haemorrhage
J. Neurol. Neurosurg. Psychiatry,
November 1, 2005;
76(11):
1565 - 1569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Guidet, P. Aegerter, R. Gauzit, P. Meshaka, D. Dreyfuss, and on behalf of the CUB-Rea Study Group
Incidence and Impact of Organ Dysfunctions Associated With Sepsis
Chest,
March 1, 2005;
127(3):
942 - 951.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alberti, C. Brun-Buisson, S. Chevret, M. Antonelli, S. V. Goodman, C. Martin, R. Moreno, A. R. Ochagavia, M. Palazzo, K. Werdan, et al.
Systemic Inflammatory Response and Progression to Severe Sepsis in Critically Ill Infected Patients
Am. J. Respir. Crit. Care Med.,
March 1, 2005;
171(5):
461 - 468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Corona, A. P. R. Wilson, M. Grassi, and M. Singer
Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy
J. Antimicrob. Chemother.,
October 1, 2004;
54(4):
809 - 817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alberti, C. Brun-Buisson, S. V. Goodman, D. Guidici, J. Granton, R. Moreno, M. Smithies, O. Thomas, A. Artigas, and J. R. Le Gall
Influence of Systemic Inflammatory Response Syndrome and Sepsis on Outcome of Critically Ill Infected Patients
Am. J. Respir. Crit. Care Med.,
July 1, 2003;
168(1):
77 - 84.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Angus
Is Pneumonia Still the Old Man's Friend?--Reply
Arch Intern Med,
June 23, 2003;
163(12):
1492 - 1492.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Valles, J. Rello, A. Ochagavia, J. Garnacho, and M. A. Alcala
Community-Acquired Bloodstream Infection in Critically Ill Adult Patients: Impact of Shock and Inappropriate Antibiotic Therapy on Survival
Chest,
May 1, 2003;
123(5):
1615 - 1624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. A. Krueger, F.-P. Lenhart, G. Neeser, G. Ruckdeschel, H. Schreckhase, H.-J. Eissner, H. Forst, J. Eckart, K. Peter, and K. E. Unertl
Influence of Combined Intravenous and Topical Antibiotic Prophylaxis on the Incidence of Infections, Organ Dysfunctions, and Mortality in Critically Ill Surgical Patients: A Prospective, Stratified, Randomized, Double-Blind, Placebo-controlled Clinical Trial
Am. J. Respir. Crit. Care Med.,
October 15, 2002;
166(8):
1029 - 1037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Alexander and E. Th. Rietschel
Invited review: Bacterial lipopolysaccharides and innate immunity
Innate Immunity,
June 1, 2001;
7(3):
167 - 202.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. RENAUD and C. BRUN-BUISSON
Outcomes of Primary and Catheter-related Bacteremia . A Cohort and Case-Control Study in Critically Ill Patients
Am. J. Respir. Crit. Care Med.,
June 1, 2001;
163(7):
1584 - 1590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. B. Malgrange, M. C. Escande, and S. Theobald
Validity of Earlier Positivity of Central Venous Blood Cultures in Comparison with Peripheral Blood Cultures for Diagnosing Catheter-Related Bacteremia in Cancer Patients
J. Clin. Microbiol.,
January 1, 2001;
39(1):
274 - 278.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. A. Thomas, Y. Li, T. Kodama, H. Suzuki, S. C. Silverstein, and J. El Khoury
Protection from Lethal Gram-positive Infection by Macrophage Scavenger Receptor-dependent Phagocytosis
J. Exp. Med.,
January 3, 2000;
191(1):
147 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. J. Bossink, A. B. J. Groeneveld, C. E. Hack, and L. G. Thijs
The Clinical Host Response to Microbial Infection in Medical Patients With Fever
Chest,
August 1, 1999;
116(2):
380 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Kollef, G. Sherman, S. Ward, and V. J. Fraser
Inadequate Antimicrobial Treatment of Infections: A Risk Factor for Hospital Mortality Among Critically Ill Patients
Chest,
February 1, 1999;
115(2):
462 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|